82 results
8-K
EX-10.1
FBRX
Forte Biosciences Inc
20 Sep 23
Departure of Directors or Certain Officers
4:15pm
on the date that a majority of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election … is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this subsection (b), if any Person
DFAN14A
5kx ne0j552no
6 Sep 23
Additional proxy materials by non-management
4:31pm
DEFA14A
9b7u5 2l1vwdu1
1 Sep 23
Additional proxy soliciting materials
5:25pm
DFAN14A
yslzdx1ggi 2ku3vk
25 Aug 23
Additional proxy materials by non-management
5:17pm
DEFC14A
vud14it52m6c981d
25 Aug 23
Proxy in contested solicitation
10:10am
DEFC14A
0gjaxjjhcmgyfo lw6w4
24 Aug 23
Proxy in contested solicitation
6:15am
PRRN14A
c508m gscxdq
17 Aug 23
Revised preliminary proxy statement filed by non-management
9:30am
PREC14A
8vud4dfgx53q
2 Aug 23
Preliminary proxy with contested solicitation
5:28pm
8-K
EX-10.2
7oeudaylr8hw4fmp
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm
8-K
EX-4.1
5w3ylke0slizap
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm
8-K
EX-10.1
d4jz17ja1ivdj6 c8mu
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm
PREC14A
ugosfr49odyuq5e7ptm
25 May 23
Preliminary proxy with contested solicitation
3:51pm
424B5
i811x
12 Aug 22
Prospectus supplement for primary offering
4:46pm
8-K
EX-4.1
xckvb21f47nxmyfoe0
12 Jul 22
Entry into a Material Definitive Agreement
9:12am